171 related articles for article (PubMed ID: 35237464)
1. Case Study: A Precision Medicine Approach to Multifactorial Dementia and Alzheimer's Disease.
Ross MK; Raji C; Lokken KL; Bredesen DE; Roach JC; Funk CC; Price N; Rappaport N; Hood L; Heath JR
J Alzheimers Dis Parkinsonism; 2021; 11(Suppl 5):. PubMed ID: 35237464
[TBL] [Abstract][Full Text] [Related]
2. The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design.
Roach JC; Hara J; Fridman D; Lovejoy JC; Jade K; Heim L; Romansik R; Swietlikowski A; Phillips S; Rapozo MK; Shay MA; Fischer D; Funk C; Dill L; Brant-Zawadzki M; Hood L; Shankle WR
Alzheimers Dement (N Y); 2022; 8(1):e12318. PubMed ID: 35910672
[TBL] [Abstract][Full Text] [Related]
3. A systems-biology clinical trial of a personalized multimodal lifestyle intervention for early Alzheimer's disease.
McEwen SC; Merrill DA; Bramen J; Porter V; Panos S; Kaiser S; Hodes J; Ganapathi A; Bell L; Bookheimer T; Glatt R; Rapozo M; Ross MK; Price ND; Kelly D; Funk CC; Hood L; Roach JC
Alzheimers Dement (N Y); 2021; 7(1):e12191. PubMed ID: 34295960
[TBL] [Abstract][Full Text] [Related]
4. A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes.
Roach JC; Rapozo MK; Hara J; Glusman G; Lovejoy J; Shankle WR; Hood L;
J Alzheimers Dis; 2023; 96(2):591-607. PubMed ID: 37840487
[TBL] [Abstract][Full Text] [Related]
5. ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline.
Rao RV; Kumar S; Gregory J; Coward C; Okada S; Lipa W; Kelly L; Bredesen DE
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680464
[TBL] [Abstract][Full Text] [Related]
6. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
[TBL] [Abstract][Full Text] [Related]
7. Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy.
Hausman-Cohen S; Bilich C; Kapoor S; Maristany E; Stefani A; Wilcox A
Front Aging Neurosci; 2022; 14():862362. PubMed ID: 35517054
[TBL] [Abstract][Full Text] [Related]
8. Clinical Lifestyle Medicine Strategies for Preventing and Reversing Memory Loss in Alzheimer's.
Shetty P; Youngberg W
Am J Lifestyle Med; 2018; 12(5):391-395. PubMed ID: 30283265
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle.
Chételat G
J Alzheimers Dis; 2018; 64(s1):S199-S211. PubMed ID: 29504542
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.
Sindi S; Thunborg C; Rosenberg A; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Håkansson K; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Kekkonen E; Rydström A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
J Prev Alzheimers Dis; 2022; 9(1):30-39. PubMed ID: 35098971
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Precision Prevention - A New Direction in Alzheimer's Disease.
Barbera M; Perera D; Matton A; Mangialasche F; Rosenberg A; Middleton L; Ngandu T; Solomon A; Kivipelto M
J Prev Alzheimers Dis; 2023; 10(4):718-728. PubMed ID: 37874092
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
13. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
[TBL] [Abstract][Full Text] [Related]
14. The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
de la Torre J
J Alzheimers Dis; 2018; 63(1):35-52. PubMed ID: 29614675
[TBL] [Abstract][Full Text] [Related]
15. Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.
Rosenberg A; Mangialasche F; Ngandu T; Solomon A; Kivipelto M
J Prev Alzheimers Dis; 2020; 7(1):29-36. PubMed ID: 32010923
[TBL] [Abstract][Full Text] [Related]
16. Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia.
van der Flier WM; de Vugt ME; Smets EMA; Blom M; Teunissen CE
Nat Aging; 2023 May; 3(5):494-505. PubMed ID: 37202515
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers and Precision Medicine in Alzheimer's Disease.
Sagar R; Pathak P; Pandur B; Kim SJ; Li J; Mahairaki V
Adv Exp Med Biol; 2021; 1339():403-408. PubMed ID: 35023132
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
